关于炎症性肠病静脉血栓栓塞风险、预防和治疗的共识声明：加拿大胃肠病学协会

2021-09-01 美国胸科医师学会 Gastroenterology . 2014 Mar;146(3):835-848.e6

背景和目的：美国胸科医师学会的静脉血栓栓塞 (VTE) 管理指南并未针对炎症性肠病 (IBD) 患者，后者是 VTE 和胃肠道出血的高风险人群。我们提出了预防和治疗 IBD 患者 VTE 的建议。

中文标题：

英文标题：

Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology

发布机构：

美国胸科医师学会

发布日期：

2021-09-01

简要介绍：

背景和目的：美国胸科医师学会的静脉血栓栓塞 (VTE) 管理指南并未针对炎症性肠病 (IBD) 患者，后者是 VTE 和胃肠道出血的高风险人群。我们提出了预防和治疗 IBD 患者 VTE 的建议。

方法：进行了系统的文献检索，以确定 IBD 中 VTE 的研究。根据推荐评估、制定和评估分级 (GRADE) 方法对证据质量和推荐强度进行评级。声明是通过一个迭代的在线平台制定的，然后由成人和儿童胃肠病学家和血栓形成专家组成的工作组最终确定和投票。

结果：与没有 IBD 的个体相比，IBD 患者发生 VTE 的风险大约高 3 倍，并且疾病发作进一步增加了这种风险。对于因 IBD 发作而住院且无活动性出血的 IBD 患者，推荐使用抗凝血栓预防，并且在出血不严重时推荐。对于因 IBD 突发或无端 VTE 引起的 VTE 病史的门诊患者，建议在中重度 IBD 突发期间进行抗凝血栓预防，但在其他情况下则不然。第一次 VTE 后推荐的抗凝持续时间基于诱发因素的存在。对儿科和妊娠期IBD患者VTE的防治提出具体建议。

结论：我们以美国胸科医师学会的指南为基础，整合了 IBD 研究的证据，为这一高危人群的 VTE 管理制定了具体的建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=0f8171c002181ea3, title=关于炎症性肠病静脉血栓栓塞风险、预防和治疗的共识声明：加拿大胃肠病学协会 , enTitle=Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology, guiderFrom=Gastroenterology . 2014 Mar;146(3):835-848.e6, authorId=0, author=, summary=背景和目的：美国胸科医师学会的静脉血栓栓塞 (VTE) 管理指南并未针对炎症性肠病 (IBD) 患者，后者是 VTE 和胃肠道出血的高风险人群。我们提出了预防和治疗 IBD 患者 VTE 的建议。, cover=, journalId=0, articlesId=null, associationId=180, associationName=美国胸科医师学会, associationIntro=提供胸科疾病指南, 《chest》是美国胸科医师学会旗下期刊。, copyright=0, guiderPublishedTime=Wed Sep 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=背景和目的：美国胸科医师学会的静脉血栓栓塞 (VTE) 管理指南并未针对炎症性肠病 (IBD) 患者，后者是 VTE 和胃肠道出血的高风险人群。我们提出了预防和治疗 IBD 患者 VTE 的建议。 方法：进行了系统的文献检索，以确定 IBD 中 VTE 的研究。根据推荐评估、制定和评估分级 (GRADE) 方法对证据质量和推荐强度进行评级。声明是通过一个迭代的在线平台制定的，然后由成人和儿童胃肠病学家和血栓形成专家组成的工作组最终确定和投票。 结果：与没有 IBD 的个体相比，IBD 患者发生 VTE 的风险大约高 3 倍，并且疾病发作进一步增加了这种风险。对于因 IBD 发作而住院且无活动性出血的 IBD 患者，推荐使用抗凝血栓预防，并且在出血不严重时推荐。对于因 IBD 突发或无端 VTE 引起的 VTE 病史的门诊患者，建议在中重度 IBD 突发期间进行抗凝血栓预防，但在其他情况下则不然。第一次 VTE 后推荐的抗凝持续时间基于诱发因素的存在。对儿科和妊娠期IBD患者VTE的防治提出具体建议。 结论：我们以美国胸科医师学会的指南为基础，整合了 IBD 研究的证据，为这一高危人群的 VTE 管理制定了具体的建议。, tagList=[TagDto(tagId=1125, tagName=炎症性肠病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2591, appHits=91, showAppHits=0, pcHits=317, showPcHits=2498, likes=0, shares=14, comments=8, approvalStatus=1, publishedTime=Fri Sep 10 11:54:19 CST 2021, publishedTimeString=2021-09-01, pcVisible=1, appVisible=1, editorId=4754896, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=小小医者, createdTime=Fri Sep 10 11:53:57 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Wed Jan 03 08:27:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])

66.pdf

下载请点击：

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1078257, encodeId=7f5510e825796, content=棒棒哒！学习了谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 01:30:15 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059038, encodeId=2f45105903805, content=会好好看的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30c35618671, createdName=ms2000000821577952, createdTime=Sat Oct 09 20:00:54 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055291, encodeId=8497105529176, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97785137592, createdName=1466c570m91暂无昵称, createdTime=Mon Sep 27 11:06:22 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016415, encodeId=4dca1016415c1, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Fri Sep 10 21:54:35 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016334, encodeId=97911016334ce, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d985545290, createdName=ms7000001697283525, createdTime=Fri Sep 10 14:11:56 CST 2021, time=2021-09-10, status=1, ipAttribution=)]
2021-12-09 一己怀

棒棒哒！学习了谢谢！

49 0
[GetPortalCommentsPageByObjectIdResponse(id=1078257, encodeId=7f5510e825796, content=棒棒哒！学习了谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 01:30:15 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059038, encodeId=2f45105903805, content=会好好看的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30c35618671, createdName=ms2000000821577952, createdTime=Sat Oct 09 20:00:54 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055291, encodeId=8497105529176, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97785137592, createdName=1466c570m91暂无昵称, createdTime=Mon Sep 27 11:06:22 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016415, encodeId=4dca1016415c1, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Fri Sep 10 21:54:35 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016334, encodeId=97911016334ce, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d985545290, createdName=ms7000001697283525, createdTime=Fri Sep 10 14:11:56 CST 2021, time=2021-09-10, status=1, ipAttribution=)]
2021-10-09 ms2000000821577952

会好好看的

98 0
[GetPortalCommentsPageByObjectIdResponse(id=1078257, encodeId=7f5510e825796, content=棒棒哒！学习了谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 01:30:15 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059038, encodeId=2f45105903805, content=会好好看的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30c35618671, createdName=ms2000000821577952, createdTime=Sat Oct 09 20:00:54 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055291, encodeId=8497105529176, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97785137592, createdName=1466c570m91暂无昵称, createdTime=Mon Sep 27 11:06:22 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016415, encodeId=4dca1016415c1, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Fri Sep 10 21:54:35 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016334, encodeId=97911016334ce, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d985545290, createdName=ms7000001697283525, createdTime=Fri Sep 10 14:11:56 CST 2021, time=2021-09-10, status=1, ipAttribution=)]
2021-09-27 1466c570m91暂无昵称

好好学习

0 0
[GetPortalCommentsPageByObjectIdResponse(id=1078257, encodeId=7f5510e825796, content=棒棒哒！学习了谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 01:30:15 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059038, encodeId=2f45105903805, content=会好好看的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30c35618671, createdName=ms2000000821577952, createdTime=Sat Oct 09 20:00:54 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055291, encodeId=8497105529176, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97785137592, createdName=1466c570m91暂无昵称, createdTime=Mon Sep 27 11:06:22 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016415, encodeId=4dca1016415c1, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Fri Sep 10 21:54:35 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016334, encodeId=97911016334ce, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d985545290, createdName=ms7000001697283525, createdTime=Fri Sep 10 14:11:56 CST 2021, time=2021-09-10, status=1, ipAttribution=)]
2021-09-10 ms8000000387487195

好好学习

101 0
[GetPortalCommentsPageByObjectIdResponse(id=1078257, encodeId=7f5510e825796, content=棒棒哒！学习了谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Thu Dec 09 01:30:15 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059038, encodeId=2f45105903805, content=会好好看的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30c35618671, createdName=ms2000000821577952, createdTime=Sat Oct 09 20:00:54 CST 2021, time=2021-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055291, encodeId=8497105529176, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97785137592, createdName=1466c570m91暂无昵称, createdTime=Mon Sep 27 11:06:22 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016415, encodeId=4dca1016415c1, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f215550116, createdName=ms8000000387487195, createdTime=Fri Sep 10 21:54:35 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016334, encodeId=97911016334ce, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d985545290, createdName=ms7000001697283525, createdTime=Fri Sep 10 14:11:56 CST 2021, time=2021-09-10, status=1, ipAttribution=)]
2021-09-10 ms7000001697283525

很不错

96 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

消化指南

关于炎症性肠病静脉血栓栓塞风险、预防和治疗的共识声明：加拿大胃肠病学协会

相关指南

科室

工具

服务